Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Columbia Univ. Brain Imaging Ctr. Routinely Injected Mental Pts. w/ Potentially Dangerous
Columbia University Brain Imaging Center Routinely Injected Mental Patients with Drugs that Contained Potentially Dangerous Impurities

July 18th, 2010 The article describes the “impurities” as, “Unknown chemicals that may or may not be related to the tracer itself.”
In other words, the victims could have been injected with anything.
As usual, the New York Times fails to provide any context for this atrocity du jour, but feel free to build that context on your own, if you dare, and probably best not before bedtime.
The Plutonium Files: America’s Secret Medical Experiments in the Cold War by Eileen Welsome
In the Name of Science: A History of Secret Programs, Medical Research, and Human Experimentation by Andrew Goliszek
Undue Risk: Secret State Experiments on Humans by Jonathan D. Moreno
Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present by Harriet A. Washington
Human Medical Experimentation in the United States: The Shocking True History of Modern Medicine and Psychiatry (1833-1965):
The United States claims to be the world leader in medicine. But there’s a dark side to western medicine that few want to acknowledge: The horrifying medical experiments performed on impoverished people and their children all in the name of scientific progress. Many of these medical experiments were conducted on people without their knowledge, and most were conducted as part of an effort to seek profits from newly approved drugs or medical technologies.
Very recently:
Scientific Fraud in Medicine:
This misconduct is a consequence of the large financial interests in studies of drugs and other treatments. A minor change in the percentage of people benefiting from a treatment in a study could affect billions of dollars in future sales. We know that most of these clinical studies are reporting false and misleading results from statistical considerations alone. We need to add a specific bias from fraud and data manipulation. When deliberate deception is included, we conclude that modern “evidence-based” medicine needs a health warning.
Pfizer to Pay $142 Million for Drug Fraud
Merck Ghost Wrote Drug Studies for Doctors
SmithKline Hid Test Data on Dangerous Diabetes Drug
On and on. To many to mention.
And now…
Via: New York Times:
Columbia University has quietly suspended research at a nationally prominent brain-imaging center and reassigned its top managers after federal investigators found that it had routinely injected mental patients with drugs that contained potentially dangerous impurities.
The investigations found that the center — regarded by experts as the nation’s leader in the use of positron emission tomography, or PET, for psychiatric research — repeatedly violated Food and Drug Administration regulations over a four-year period.
“Failure to promptly correct these violations may result in legal action without further notice,” the agency wrote to Columbia in December 2008, citing lax internal quality control and sloppy procedures for formulating drug injections.
F.D.A. investigators returned in January 2010 and found that many of the center’s lab’s practices had not changed, and cited a long list of specific violations, including one instance in which the staff hid impurities from auditors by falsifying documents.
“They raided the place like it was a crime scene, seizing hard drives,” said one former lab worker, who requested anonymity because he feared reprisals from the university.
In a statement, the university said on Friday that it had conducted its own investigation of the lab at the request of the F.D.A. had and reported to the agency on July 6 that it found no evidence of harm to patients. The F.D.A. did not publicize its investigations; The New York Times learned of them from doctors who were familiar with the lab’s problems.
The office under fire, the Kreitchman PET Center, on West 168th Street in Manhattan, has attracted millions of dollars in research funds from the federal government and pharmaceutical companies to study drug actions and the biology of brain disorders, among other things.
Many of its studies focus on patients with disorders like schizophrenia and severe depression, who are especially vulnerable to poorly prepared imaging drugs because the compounds can act on brain receptors involved in their illness.
“We acknowledge serious shortcomings of quality control in the manufacturing process and record-keeping at this lab,” said David I. Hirsh, Columbia’s executive vice president for research. “That is why we are fundamentally reorganizing the lab’s management and operations in response to what the F.D.A. told us.”
To perform a PET scan, doctors must first inject patients with a radiotracer, a drug engineered to accumulate in the area of the body being studied and to emit low-level radiation detectable by a scanner.
The compounds are considered very safe. But because they degrade quickly, many laboratories produce them themselves, under protocols agreed upon with the F.D.A.
The agency regulates the allowable radiation levels and the purity of the drugs. If a drug contains too many impurities — unknown chemicals that may or may not be related to the tracer itself — then its effects in the body are unpredictable.
“There could be a patient safety issue, for one,” said Dr. Barry Siegel, chairman of the radioactive drug research committee at Washington University in St. Louis. “And there could be a scientific validity issue. If you’re exposing people to radiation and getting garbage data, then that becomes an ethical problem.”
That is particularly true when it comes to psychiatric research. Radiotracers that target receptors in the brain, as used in many of the Columbia studies, are more prone than other PET drugs to be biologically active — to affect mood or behavior, especially in those who already suffer from severe depression or other mental problems. “You have to have additional quality-assurance procedures if you’re using agents that bind receptors in brain,” said Dr. Dennis P. Swanson, chairman of the radiation safety commission at the University of Pittsburgh.
The F.D.A.’s latest investigation, which took place from Jan. 5 to Jan. 21, listed six categories of violations. It found that since 2007, “at least 10 batches” of drugs had been “released and injected into human subjects” with impurities that exceeded the level the lab had agreed to set. At least four injections “had impurity masses that more than doubled the maximum limit implemented.”
The report highlighted an equation that the lab routinely used, resulting in injections that exceeded the limit for acceptable impurities. The lab did not adequately check “the identity, strength and purity of each active ingredient prior to release” for injection into patients, the report said.
Agency investigators also found a forged document, a hard copy record that had been altered to hide a drug impurity that showed up clearly in the computer records.
Former employees, speaking on the condition of anonymity because they worked in the imaging field or hoped to, said those practices were not only commonplace but also condoned. They described a center under such pressure to produce studies that it papered over and hid impurities in drugs to stretch its resources and went ahead with business as usual despite F.D.A. warnings.
“These are not the actions of a rogue, but instead are systematic forgeries condoned and approved by the lab director,” wrote one employee in a 2009 resignation letter addressed to Dr. Ronald L. Van Heertum, the PET center’s co-director at the time.
Columbia’s internal audit concluded that this and other charges had “sufficient substance to warrant an investigation,” according to documents obtained by The Times. Among the charges was one that the lab replaced a compound it was testing for the drug maker Eli Lilly with one it was testing for Novartis — and did not mention the switch in its report to Eli Lilly.
Neither Dr. Van Heertum, a radiologist, nor his former co-director, Dr. J. John Mann, a psychiatrist, returned calls seeking comment on Friday.
In his statement, Dr. Hirsh said, “When manufacturing resumes under new leadership, it will meet the strictest standards and best practices for ensuring the quality” of the PET drugs.
He said the center’s clinical, nonresearch side was not affected by the suspension, adding that it was “fully approved and operational” and remained open for patient care.
"Where is the intersection between the world's deep hunger and your deep gladness?"

Possibly Related Threads…
Thread Author Replies Views Last Post
  Hard-wired: The brain's circuitry for political belief Peter Lemkin 0 8,837 24-12-2016, 12:46 PM
Last Post: Peter Lemkin
  Neuroscientist Is Trying to Upload His Entire Brain to a Computer Peter Lemkin 1 12,706 22-12-2014, 10:33 AM
Last Post: Magda Hassan
  UCLA’s Dr. W. Ross Adey & Remote Brain Telemetry Peter Lemkin 16 21,700 16-06-2014, 05:02 PM
Last Post: Michael Barwell
  Bird flu virus engineered to be dangerous to humans David Guyatt 0 2,571 21-12-2013, 11:00 AM
Last Post: David Guyatt
  Canadian Scientists Charged with Smuggling Dangerous and Highly Contagious Pathogens from China Magda Hassan 4 3,641 11-04-2013, 06:07 PM
Last Post: Jan Klimkowski
  Telepathic rats, with a little help from brain implants....what next for humans? Peter Lemkin 3 3,805 01-03-2013, 09:01 PM
Last Post: Charles Drago
  New DSM manual is 'dangerous' say specialists. Magda Hassan 2 2,962 19-02-2012, 08:06 AM
Last Post: Magda Hassan
  Air Force’s Top Brain Wants a ‘Social Radar’ to ‘See Into Hearts and Minds’ Ed Jewett 0 2,681 21-01-2012, 03:13 AM
Last Post: Ed Jewett
  OTC: The Risks of Dangerous Research Bernice Moore 0 2,211 19-01-2012, 02:11 PM
Last Post: Bernice Moore
  Raytheon develops new and potentially lethal crowd control weapon. Peter Lemkin 1 3,417 16-12-2011, 11:33 AM
Last Post: Magda Hassan

Forum Jump:

Users browsing this thread: 1 Guest(s)